Key result
Olmesartan reduces hippocampal blood-brain barrier leakage ~18 percentage points and preserves cognition in hypertensive rats.
Why the study?
Does olmesartan improve cognitive function and prevent blood-brain barrier disruption in Dahl salt-sensitive hypertensive rats?
Does olmesartan improve cognitive function and prevent blood-brain barrier disruption in Dahl salt-sensitive hypertensive rats?
In a rat model of salt-dependent hypertension, AT1 receptor blockade with olmesartan provided neuroprotection and improved cognition independently of blood pressure reduction.
Answers are grounded in this paper and cite their sources.
Supports BP-independent hippocampal protection by olmesartan in salt-sensitive rats; hypothesis-generating and leaves open human translation.
BACKGROUND: The present study tested the hypothesis that inappropriate activation of the brain renin-angiotensin system (RAS) contributes to the pathogenesis of blood-brain barrier (BBB) disruption and cognitive impairment during development of salt-dependent hypertension. Effects of an angiotensin II (AngII) type-1 receptor blocker (ARB), at a dose that did not reduce blood pressure, were also examined. METHODS: Dahl salt-sensitive (DSS) rats at 6 weeks of age were assigned to three groups: low-salt diet (DSS/L; 0.3% NaCl), high-salt diet (DSS/H; 8% NaCl), and high-salt diet treated with ARB, olmesartan at 1 mg/kg. RESULTS: DSS/H rats exhibited hypertension, leakage from brain microvessels in the hippocampus, and impaired cognitive functions, which were associated with increased brain AngII levels, as well as decreased mRNA levels of tight junctions (TJs) and collagen-IV in the hippocampus. In DSS/H rats, olmesartan treatment, at a dose that did not alter blood pressure, restored the cognitive decline, and ameliorated leakage from brain microvessels. Olmesartan also decreased brain AngII levels and restored mRNA expression of TJs and collagen-IV in DSS/H rats. CONCLUSIONS: These results suggest that during development of salt-dependent hypertension, activation of the brain RAS contributes to BBB disruption and cognitive impairment. Treatment with an ARB could elicit neuroprotective effects in cognitive disorders by preventing BBB permeability, which is independent of blood pressure changes.
No takes yet. Share an insight, caveat, or question.
Pelisch et al. (2010) studied Salt-dependent hypertension, blood-brain barrier disruption, and cognitive impairment (n=48). Olmesartan (with high-salt diet, 8% NaCl) vs. Untreated high-salt diet (8% NaCl) and low-salt diet (0.3% NaCl) was evaluated on Blood-brain barrier microvessel permeability (% leakage of horseradish peroxidase-tetramethylbenzidine in the hippocampus and corpus callosum) (p=<0.01). Olmesartan reduced hippocampal blood-brain barrier leakage from 34% to 16% and ameliorated cognitive decline in high-salt Dahl rats without altering systolic blood pressure.
Synapse has enriched 10 related papers. Consider them for comparative context: